Novavax Inc. sell JPMorgan Chase & Co.
Start price
18.11.25
/
50%
€5.63
Target price
18.11.26
€5.18
Performance (%)
52.31%
Price
27.02.26
€8.58
Summary
This prediction is currently active. The SELL prediction by JPMorgan_Chase___Co_ for Novavax Inc. is trending in the completely wrong direction and now has a performance of 52.31%. This prediction currently runs until 18.11.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novavax Inc. | 9.707% | 9.707% |
| iShares Core DAX® | -0.383% | 1.093% |
| iShares Nasdaq 100 | -0.411% | -1.973% |
| iShares Nikkei 225® | 1.838% | 10.261% |
| iShares S&P 500 | -0.712% | 0.445% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Novavax Inc. diskutieren
Novavax (NASDAQ:NVAX) had its price target lowered by analysts at JPMorgan Chase & Co. from $7.00 to $6.00. They now have an "underweight" rating on the stock.
Ratings data for NVAX provided by MarketBeat